Promises And Pitfalls Of Regenerative Therapies For Androgenetic Alopecia: Platelet-Rich Plasma, Photobiomodulation, Stem Cells, And Exosomes
January 2025
in “
Open Science Framework
”
TLDR Current evidence is insufficient to fully endorse regenerative therapies for hair loss.
This review explores the potential and challenges of regenerative therapies for androgenetic alopecia (AGA), focusing on platelet-rich plasma (PRP), photobiomodulation (PBM), stem cells, and exosomes. AGA is a common hair loss condition affecting a significant portion of the population. PRP and PBM are already used in clinical settings, while stem cells and exosomes are still under investigation due to regulatory and safety concerns. The review systematically analyzes clinical evidence from the past 5 years, examining the mechanisms, efficacy, and safety of these treatments. The findings suggest that regenerative therapies may offer promising results in improving hair density and thickness, although more high-quality empirical evidence is needed to establish standardized treatment protocols.